MUC4/16 assay for the early diagnosis and management of benign and malignant pancreatic diseases
Ended Project Grant Awarded Last action
- Award ID
- R44DK117472
- Recipient
-
Sanguine Diagnostics & Therapeutics Inc. UEI ECGMLSHGH4X6
- Awarding agency
-
National Institute of Diabetes and Digestive and Kidney Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,369,737
Award facts
- Assistance listing
- 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research
- Completion date
- Originally
- Place of performance
- Omaha, NE 68106, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | -$144,709 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $657,713 | |
| Amendment | -$123,203 | |
| Amendment | $123,203 | |
| Amendment | $657,713 | |
| Original award | $199,020 |
Show all 14
Quick answers
Who received award R44DK117472?
R44DK117472 was awarded to Sanguine Diagnostics & Therapeutics Inc. by National Institute of Diabetes and Digestive and Kidney Diseases (National Institutes of Health) on September 12, 2017.
How much is award R44DK117472 worth?
$1,369,737 has been obligated on R44DK117472.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award